Is Atrovent (ipratropium bromide) 0.03% nasal spray used for allergic rhinitis, and is an inhaler formulation of ipratropium bromide available?

Atrovent 0.03% Nasal Spray for Allergic Rhinitis and Inhaler Availability

Yes, Atrovent (ipratropium bromide) 0.03% nasal spray is FDA-approved and effective for treating rhinorrhea (runny nose) caused by perennial allergic rhinitis, and yes, ipratropium bromide is also available as an inhaler formulation (Atrovent HFA) for bronchospasm.

Nasal Spray for Allergic Rhinitis

Atrovent nasal spray 0.03% is specifically approved for rhinorrhea in allergic rhinitis but only treats the runny nose component—not congestion, sneezing, or other allergy symptoms 1. The medication works as an anticholinergic agent that blocks parasympathetic-mediated nasal secretions locally without significant systemic absorption 1.

Key Clinical Points:

• Approved indication: Rhinorrhea from perennial allergic and nonallergic rhinitis in patients ≥6 years old 1
• Mechanism: Reduces only nasal secretions; has no effect on congestion, sneezing, or itching 1
• Onset: Benefit evident within the first day to first week of treatment 2, 3, 4
• Safety profile: Well-tolerated with minimal side effects—epistaxis (9% vs 5% placebo) and nasal dryness (5% vs 1% placebo) 1

When to Use:

Use ipratropium 0.03% nasal spray when rhinorrhea is the predominant or isolated symptom in allergic rhinitis. For patients with multiple symptoms (congestion, sneezing, itching), intranasal corticosteroids remain first-line treatment as they address all symptoms more comprehensively 1, 5, 6.

Combination therapy with intranasal corticosteroids plus ipratropium is more effective than either agent alone for controlling rhinorrhea without increasing adverse events 1, 2. This approach should be considered when rhinorrhea persists despite corticosteroid monotherapy or when rhinorrhea is particularly bothersome 2.

Important Caveats:

• The 0.03% concentration is for allergic/perennial rhinitis; the 0.06% concentration is specifically for common cold rhinorrhea 1
• Ipratropium does not alter other nasal functions (smell, ciliary clearance, mucociliary function) 1
• No rebound effect occurs after discontinuation 3
• Can be combined with antihistamines for additive benefit 1

Inhaler Formulation Availability

Yes, ipratropium bromide is available as Atrovent HFA, a metered-dose inhaler for oral inhalation 7. This is a completely different formulation and indication from the nasal spray.

Inhaler Specifications:

• Formulation: Pressurized metered-dose aerosol with HFA-134a propellant (CFC-free) 7
• Dosing: Each actuation delivers 17 mcg ipratropium bromide from the mouthpiece 7
• Indication: Bronchospasm treatment (not for rhinitis)
• Also available: Nebulizer solution (0.02%) for oral inhalation 8

Critical Distinction:

The inhaler and nasal spray are NOT interchangeable—they treat different conditions (bronchospasm vs rhinorrhea) through different routes and cannot substitute for one another 7.

Clinical Algorithm for Ipratropium Use in Rhinitis:

1. Isolated rhinorrhea: Start ipratropium 0.03% nasal spray alone
2. Rhinorrhea + other symptoms: Start intranasal corticosteroid; add ipratropium if rhinorrhea persists
3. Severe rhinorrhea from onset: Consider combination intranasal corticosteroid + ipratropium from the start 2
4. Monitor response: Benefit should be evident within 1 week 3, 4